Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 843-858
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.843
Figure 3
Figure 3 Long-term overall survival and cancer-specific survival outcomes using Kaplan-Meier analysis. A and B: Overall survival (OS) and cancer-specific survival (CSS) were better for invasive intraductal papillary neoplasm of the bile duct (IPNB) and worse for invasive intraductal papillary mucinous neoplasm of the pancreas (IPMN) compared with traditional cholangiocarcinoma (P < 0.001); C and D: OS and CSS in individuals with the non-mucin subtype of invasive IPNB was better than for the mucin subtype (P < 0.05); E and F: OS and CSS in individuals with invasive IPNB at distal sites and at the pancreaticobiliary ampulla was better than at other sites (P < 0.001); G and H: OS and CSS in individuals with invasive IPNB with defined radical surgery was better than other type of surgical treatment (P < 0.001).